APLASTIC-ANEMIA IN NEONATAL LUPUS-ERYTHEMATOSUS

被引:27
作者
WOLACH, B
CHOC, L
POMERANZ, A
BENARI, Y
DOUER, D
METZKER, A
机构
[1] CHAIM SHEBA MED CTR,INST HEMATOL,IL-52621 TEL HASHOMER,ISRAEL
[2] SAPIR MED CTR,MEIR GEN HOSP,PEDIAT HEMATOL UNIT,KEFAR SAVA,ISRAEL
[3] CHILDRENS MED CTR,PEDIAT DERMATOL UNIT,PETAH TIQWA,ISRAEL
[4] TEL AVIV UNIV,SACKLER SCH MED,TEL AVIV,ISRAEL
来源
AMERICAN JOURNAL OF DISEASES OF CHILDREN | 1993年 / 147卷 / 09期
关键词
D O I
10.1001/archpedi.1993.02160330031012
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective.-To describe an infant with neonatal lupus erythematosus associated with aplastic anemia. Setting.-The pediatric department in a tertiary-care hospital. Interventions.-Packed red blood cell transfusions and a 3-week course of high-dose steroid therapy. Measurements/Main Results.-The patient presented with severe anemia and a circumscribed, reticular, macular rash on the face and neck at 5 months of age. Skin lesion biopsy revealed epidermic hyperkeratosis, hydropic degeneration of the basal layer, and deposition of immunoglobulins and granular C1q at the dermoepidermal junction. Ro/SS-A antibodies were present in the infant. BFU-E (erythyroid progenitor burst-forming unit) colonies in bone marrow increased by about tenfold when suppressor CD8+ T lymphocytes were removed, indicating immune suppression of hematopoiesis. High-dose steroid therapy failed. The infant subsequently developed gram-negative sepsis, severe metabolic acidosis, and consumptive coagulopathy and died. Conclusions.-Neonatal lupus erythematosus may present as part of a spectrum. The disease may range from mild and transient to a severe, life-threatening condition requiring immediate intervention, as in the case reported here. This is the first report of neonatal lupus associated with aplastic anemia due to immune-mediated suppression of hematopoiesis.
引用
收藏
页码:941 / 944
页数:4
相关论文
共 42 条
[1]   ANTI-RO SS-A ANTIBODIES IN THE PATHOPHYSIOLOGY OF CONGENITAL HEART-BLOCK IN NEONATAL LUPUS SYNDROME, AN EXPERIMENTAL-MODEL - INVITRO ELECTROPHYSIOLOGIC AND IMMUNOCYTOCHEMICAL STUDIES [J].
ALEXANDER, E ;
BUYON, JP ;
PROVOST, TT ;
GUARNIERI, T .
ARTHRITIS AND RHEUMATISM, 1992, 35 (02) :176-189
[2]  
[Anonymous], 1986, Pediatr Dermatol, V3, P417
[3]   HEMATOLOGIC ASPECTS OF SYSTEMIC LUPUS-ERYTHEMATOSUS - CURRENT CONCEPTS [J].
BUDMAN, DR ;
STEINBERG, AD .
ANNALS OF INTERNAL MEDICINE, 1977, 86 (02) :220-229
[4]   ACQUIRED CONGENITAL HEART-BLOCK - PATTERN OF MATERNAL ANTIBODY-RESPONSE TO BIOCHEMICALLY DEFINED ANTIGENS OF THE SSA/RO-SSB/LA SYSTEM IN NEONATAL LUPUS [J].
BUYON, JP ;
BENCHETRIT, E ;
KARP, S ;
ROUBEY, RAS ;
POMPEO, L ;
REEVES, WH ;
TAN, EM ;
WINCHESTER, R .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (02) :627-634
[5]   ERYTHROID APLASIA IN SYSTEMIC LUPUS ERYTHEMATOSUS [J].
CASSILETH, PA ;
MYERS, AR .
AMERICAN JOURNAL OF MEDICINE, 1973, 55 (05) :706-710
[6]   ANTI-THYMOCYTE GLOBULIN TREATMENT IN PATIENTS WITH APLASTIC-ANEMIA - A PROSPECTIVE RANDOMIZED TRIAL [J].
CHAMPLIN, R ;
HO, W ;
GALE, RP .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (03) :113-118
[7]   HUMORAL SUPPRESSION OF ERYTHROPOIESIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) AND RHEUMATOID-ARTHRITIS [J].
DAINIAK, N ;
HARDIN, J ;
FLOYD, V ;
CALLAHAN, M ;
HOFFMAN, R .
AMERICAN JOURNAL OF MEDICINE, 1980, 69 (04) :537-544
[8]  
DAUGHADAY WH, 1968, AM J MED, V44, P590
[9]   SERUM INHIBITORS OF HEMATOPOIESIS IN A PATIENT WITH APLASTIC-ANEMIA AND SYSTEMIC LUPUS-ERYTHEMATOSUS - RECOVERY AFTER EXCHANGE PLASMAPHERESIS [J].
FITCHEN, JJ ;
CLINE, MJ ;
SAXON, A ;
GOLDE, DW .
AMERICAN JOURNAL OF MEDICINE, 1979, 66 (03) :537-542
[10]  
HAQ AU, 1983, J LAB CLIN MED, V101, P53